370 related articles for article (PubMed ID: 9683807)
1. Changes of mutant-type p53 expression in squamous cell carcinoma of the head and neck during radiation therapy and its clinical significance: comparison of an immunohistochemical method and PCR-SSCP assay.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Oncol Rep; 1998; 5(5):1053-9. PubMed ID: 9683807
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2301-7. PubMed ID: 9815628
[TBL] [Abstract][Full Text] [Related]
3. Expression of fas (CD95/APO-1) antigen induced by radiation therapy for diffuse B-cell lymphoma: immunohistochemical study.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2211-6. PubMed ID: 9815617
[TBL] [Abstract][Full Text] [Related]
4. p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines.
Servomaa K; Kiuru A; Grénman R; Pekkola-Heino K; Pulkkinen JO; Rytömaa T
Cell Prolif; 1996 May; 29(5):219-30. PubMed ID: 8782485
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer.
Calzolari A; Chiarelli I; Bianchi S; Messerini L; Gallo O; Porfirio B; Mattiuz PL
Am J Clin Pathol; 1997 Jan; 107(1):7-11. PubMed ID: 8980360
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of p53 expression in cancer tissues from patients undergoing radiation therapy.
Hamada N; Ogawa Y; Seguchi H; Terashima M; Nishioka A; Inomata T; Yoshida S; Kishimoto S; Saito H
Histol Histopathol; 1995 Jul; 10(3):611-7. PubMed ID: 7579809
[TBL] [Abstract][Full Text] [Related]
7. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
8. p53 gene alternation in squamous cell carcinoma of the esophagus detected by PCR-cold SSCP analysis.
Wang LS; Chow KC; Liu CC; Chiu JH
Proc Natl Sci Counc Repub China B; 1998 Jul; 22(3):114-21. PubMed ID: 9779600
[TBL] [Abstract][Full Text] [Related]
9. Expression of p27 and p53 in cervical squamous cell carcinoma patients treated with radiotherapy alone: radiotherapeutic effect and prognosis.
Oka K; Suzuki Y; Nakano T
Cancer; 2000 Jun; 88(12):2766-73. PubMed ID: 10870059
[TBL] [Abstract][Full Text] [Related]
10. Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study.
Peltonen JK; Vähäkangas KH; Helppi HM; Bloigu R; Pääkkö P; Turpeenniemi-Hujanen T
Head Neck Oncol; 2011 Apr; 3():20. PubMed ID: 21513535
[TBL] [Abstract][Full Text] [Related]
11. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
Raybaud-Diogène H; Fortin A; Morency R; Roy J; Monteil RA; Têtu B
J Clin Oncol; 1997 Mar; 15(3):1030-8. PubMed ID: 9060543
[TBL] [Abstract][Full Text] [Related]
12. p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.
Mineta H; Borg A; Dictor M; Wahlberg P; Akervall J; Wennerberg J
Br J Cancer; 1998 Oct; 78(8):1084-90. PubMed ID: 9792155
[TBL] [Abstract][Full Text] [Related]
13. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.
Alsner J; Sørensen SB; Overgaard J
Radiother Oncol; 2001 May; 59(2):179-85. PubMed ID: 11325447
[TBL] [Abstract][Full Text] [Related]
14. Implications of p53 alterations and anti-p53 antibody response in head and neck squamous cell carcinomas.
Lavieille JP; Righini C; Reyt E; Brambilla C; Riva C
Oral Oncol; 1998 Mar; 34(2):84-92. PubMed ID: 9682769
[TBL] [Abstract][Full Text] [Related]
15. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations.
Xu L; Chen YT; Huvos AG; Zlotolow IM; Rettig WJ; Old LJ; Garin-Chesa P
Diagn Mol Pathol; 1994 Jun; 3(2):83-92. PubMed ID: 8061893
[TBL] [Abstract][Full Text] [Related]
17. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.
Nylander K; Nilsson P; Mehle C; Roos G
Br J Cancer; 1995 Apr; 71(4):826-30. PubMed ID: 7710950
[TBL] [Abstract][Full Text] [Related]
18. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.
Koch WM; Brennan JA; Zahurak M; Goodman SN; Westra WH; Schwab D; Yoo GH; Lee DJ; Forastiere AA; Sidransky D
J Natl Cancer Inst; 1996 Nov; 88(21):1580-6. PubMed ID: 8901856
[TBL] [Abstract][Full Text] [Related]
19. Tumor angiogenesis and p53 mutations: prognosis in head and neck cancer.
Hegde PU; Brenski AC; Caldarelli DD; Hutchinson J; Panje WR; Wood NB; Leurgans S; Preisler HD; Taylor SG; Caldarelli L; Coon JS
Arch Otolaryngol Head Neck Surg; 1998 Jan; 124(1):80-5. PubMed ID: 9440785
[TBL] [Abstract][Full Text] [Related]
20. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer.
Schneider-Stock R; Mawrin C; Motsch C; Boltze C; Peters B; Hartig R; Buhtz P; Giers A; Rohrbeck A; Freigang B; Roessner A
Am J Pathol; 2004 Apr; 164(4):1233-41. PubMed ID: 15039212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]